DE60335608D1 - Zusammensetzungen zur abgabe von therapeutika und anderen materialien und verfahren zu ihrer herstellung und verwendung - Google Patents
Zusammensetzungen zur abgabe von therapeutika und anderen materialien und verfahren zu ihrer herstellung und verwendungInfo
- Publication number
- DE60335608D1 DE60335608D1 DE60335608T DE60335608T DE60335608D1 DE 60335608 D1 DE60335608 D1 DE 60335608D1 DE 60335608 T DE60335608 T DE 60335608T DE 60335608 T DE60335608 T DE 60335608T DE 60335608 D1 DE60335608 D1 DE 60335608D1
- Authority
- DE
- Germany
- Prior art keywords
- compositions
- therapeutics
- delivery
- materials
- production
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- 239000000463 material Substances 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000002184 metal Substances 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 1
- 229910021645 metal ion Inorganic materials 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36035002P | 2002-02-27 | 2002-02-27 | |
| PCT/US2003/005937 WO2003072143A1 (en) | 2002-02-27 | 2003-02-27 | Compositions for delivery of therapeutics and other materials, and methods of making and using the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60335608D1 true DE60335608D1 (de) | 2011-02-17 |
Family
ID=27766225
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60335608T Expired - Lifetime DE60335608D1 (de) | 2002-02-27 | 2003-02-27 | Zusammensetzungen zur abgabe von therapeutika und anderen materialien und verfahren zu ihrer herstellung und verwendung |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7138105B2 (de) |
| EP (1) | EP1478406B1 (de) |
| JP (1) | JP2005524657A (de) |
| AT (1) | ATE494010T1 (de) |
| AU (1) | AU2003219922B2 (de) |
| CA (1) | CA2476589C (de) |
| DE (1) | DE60335608D1 (de) |
| WO (1) | WO2003072143A1 (de) |
Families Citing this family (63)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040220100A1 (en) * | 2000-07-21 | 2004-11-04 | Essentia Biosystems, Inc. | Multi-component biological transport systems |
| US20030194798A1 (en) * | 2001-05-24 | 2003-10-16 | Surber Mark W. | Minicell compositions and methods |
| CN1649628A (zh) * | 2002-02-26 | 2005-08-03 | 天藤制药株式会社 | 向脂质体中包封金属络合物的方法 |
| US7635463B2 (en) * | 2002-02-27 | 2009-12-22 | Pharmain Corporation | Compositions for delivery of therapeutics and other materials |
| US20050260259A1 (en) * | 2004-04-23 | 2005-11-24 | Bolotin Elijah M | Compositions for treatment with glucagon-like peptide, and methods of making and using the same |
| US20100069293A1 (en) * | 2002-02-27 | 2010-03-18 | Pharmain Corporation | Polymeric carrier compositions for delivery of active agents, methods of making and using the same |
| JP2005524657A (ja) * | 2002-02-27 | 2005-08-18 | ファーメイン， エルティーディー． | 治療剤及び他の物質を送達するための組成物、及び、前記組成物を作製し使用する方法 |
| US7629049B2 (en) * | 2002-10-18 | 2009-12-08 | Medasorb, Inc. | Hemocompatible polymer systems and related devices |
| WO2005010080A1 (ja) * | 2003-07-28 | 2005-02-03 | Teijin Limited | 温度応答性ハイドロゲル |
| BRPI0413086A (pt) * | 2003-07-30 | 2006-10-03 | Anteis Sa | matriz complexa, utilização da mesma, e processo de preparação de uma matriz biocompatìvel pouco biodegradável |
| EP1663186B1 (de) * | 2003-09-10 | 2007-06-20 | Cristália Produtos Químicos Farmacêuticos Ltda. | Stabile pharmazeutische zusammensetzung einer fluorether-verbindung für die anästhesie, verfahren zur stabilisierung einer fluorether-verbindung, verwendung eines stabilisierungsmittels zum ausschluss des abbaus einer fluorether-verbindung |
| US8193291B2 (en) * | 2004-02-23 | 2012-06-05 | Caiteng Zhang | Solution of metal-polymer chelate(s) and applications thereof |
| US9211248B2 (en) | 2004-03-03 | 2015-12-15 | Revance Therapeutics, Inc. | Compositions and methods for topical application and transdermal delivery of botulinum toxins |
| US8974774B2 (en) * | 2004-03-03 | 2015-03-10 | Revance Therapeutics, Inc. | Compositions and methods for topical diagnostic and therapeutic transport |
| ES2691498T3 (es) * | 2004-03-03 | 2018-11-27 | Revance Therapeutics, Inc. | Aplicación tópica y liberación transdérmica de toxinas botulínicas |
| BRPI0404983A (pt) * | 2004-09-03 | 2006-05-02 | Nanocore Biotecnologia Ltda | composições imunogênicas |
| AU2006204045B2 (en) * | 2005-01-05 | 2010-10-14 | Board Of Regents, The University Of Texas System | Conjugates for dual imaging and radiochemotherapy: composition, manufacturing, and applications |
| US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
| US20090291508A1 (en) * | 2008-05-20 | 2009-11-26 | Rapid Pathogen Screening Inc. | Nanoparticles in diagnostic tests |
| WO2006094263A2 (en) | 2005-03-03 | 2006-09-08 | Revance Therapeutics, Inc. | Compositions and methods for topical application and transdermal delivery of botulinum toxins |
| ATE475437T1 (de) | 2005-09-09 | 2010-08-15 | Aesculap Ag | Antimikrobielles medizintechnisches produkt, verfahren zu seiner herstellung und verwendung |
| JP4670583B2 (ja) * | 2005-10-20 | 2011-04-13 | チッソ株式会社 | 水溶性カチオン性磁気微粒子を用いた脂質ベシクルの分離又は検出方法 |
| CA2631931C (en) | 2005-12-01 | 2014-04-29 | Pronai Therapeutics, Inc. | Cancer therapies and pharmaceutical compositions used therein |
| AU2006330610B2 (en) * | 2005-12-19 | 2012-08-16 | Pharmain Corporation | Hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same |
| ES2422864T3 (es) | 2006-08-09 | 2013-09-16 | Intarcia Therapeutics, Inc | Sistemas de liberación osmótica y unidades de pistón |
| US9604196B2 (en) | 2006-11-20 | 2017-03-28 | Cytosorbent, Inc. | Size-selective hemocompatible polymer system |
| CA2669887A1 (en) * | 2006-11-21 | 2008-05-29 | Viamet Pharmaceuticals, Inc. | Metallo-oxidoreductase inhibitors using metal binding moieties in combination with targeting moieties |
| US20090263346A1 (en) * | 2006-12-05 | 2009-10-22 | David Taft | Systems and methods for delivery of drugs |
| EP2500015A1 (de) * | 2006-12-05 | 2012-09-19 | Landec Corporation | Verabreichung von Arzneimitteln |
| US8399007B2 (en) * | 2006-12-05 | 2013-03-19 | Landec Corporation | Method for formulating a controlled-release pharmaceutical formulation |
| US20090246155A1 (en) * | 2006-12-05 | 2009-10-01 | Landec Corporation | Compositions and methods for personal care |
| US20100004124A1 (en) * | 2006-12-05 | 2010-01-07 | David Taft | Systems and methods for delivery of materials for agriculture and aquaculture |
| WO2008128058A1 (en) * | 2007-04-13 | 2008-10-23 | The Trustees Of The University Of Pennsylvania | New gallium bisaminothiolate complexes for myocardial imaging |
| WO2008133908A2 (en) | 2007-04-23 | 2008-11-06 | Intarcia Therapeutics, Inc. | Suspension formulations of insulinotropic peptides and uses thereof |
| US10092524B2 (en) | 2008-06-11 | 2018-10-09 | Edge Therapeutics, Inc. | Compositions and their use to treat complications of aneurysmal subarachnoid hemorrhage |
| US7960336B2 (en) | 2007-08-03 | 2011-06-14 | Pharmain Corporation | Composition for long-acting peptide analogs |
| US8563527B2 (en) | 2007-08-20 | 2013-10-22 | Pharmain Corporation | Oligonucleotide core carrier compositions for delivery of nucleic acid-containing therapeutic agents, methods of making and using the same |
| US9095568B2 (en) * | 2007-09-26 | 2015-08-04 | Mark Berninger | Therapeutic and vaccine polyelectrolyte nanoparticle compositions |
| US8114883B2 (en) * | 2007-12-04 | 2012-02-14 | Landec Corporation | Polymer formulations for delivery of bioactive materials |
| US20090176892A1 (en) * | 2008-01-09 | 2009-07-09 | Pharmain Corporation | Soluble Hydrophobic Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same |
| EP2240155B1 (de) | 2008-02-13 | 2012-06-06 | Intarcia Therapeutics, Inc | Vorrichtungen, formulierungen und verfahren zur freisetzung mehrerer wirkstoffe |
| US20110044968A1 (en) * | 2008-03-10 | 2011-02-24 | Pharmal N Corporation | Compositions for treatment with metallopeptidases, methods of making and using the same |
| SG10201703039SA (en) * | 2008-09-04 | 2017-05-30 | Amylin Pharmaceuticals Llc | Sustained release formulations using non-aqueous carriers |
| EP2475358B1 (de) | 2009-09-09 | 2019-06-05 | Pharmain Corporation | Zusammensetzung mit anionischem kern zur freisetzung von therapeutika sowie verfahren zu ihrer herstellung und verwendung |
| WO2011037623A1 (en) | 2009-09-28 | 2011-03-31 | Intarcia Therapeutics, Inc. | Rapid establishment and/or termination of substantial steady-state drug delivery |
| DK2343051T3 (da) | 2010-01-05 | 2014-10-27 | Nat Univ Dong Hwa | Anti-cancer formulering |
| RU2012140441A (ru) * | 2010-02-22 | 2014-03-27 | Эдж Терапьютикс Инк. | Методы и композиции для лечения геморрагических состояний мозга |
| US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
| AU2012240131B2 (en) | 2011-04-05 | 2017-07-20 | Edge Therapeutics | Intraventricular drug delivery system for improving outcome after a brain injury affecting cerebral blood flow |
| US8785569B2 (en) * | 2011-11-22 | 2014-07-22 | Original Biomedicals Co., Ltd. | Drug carrier with chelating complex micelles and the application thereof |
| BR112015010220A2 (pt) | 2012-11-05 | 2017-12-05 | Pronai Therapeutics Inc | métodos de utilização de biomarcadores para tratamento de câncer |
| CN105764491A (zh) | 2013-12-09 | 2016-07-13 | 度瑞公司 | 药物活性剂复合物、聚合物复合物，以及包括其的组合物和方法 |
| US10563243B2 (en) | 2014-09-24 | 2020-02-18 | Colgate-Palmolive Company | Bioavailability of metal ions |
| US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
| CN113598842A (zh) | 2015-06-03 | 2021-11-05 | 因塔西亚制药公司 | 植入物放置和移除系统 |
| CN105054074A (zh) * | 2015-07-01 | 2015-11-18 | 浙江海洋学院 | 一种鱼糜酶解肽亚铁螯合物抗氧化微胶囊及其制备工艺 |
| US10258578B2 (en) | 2015-10-09 | 2019-04-16 | Pendant Biosciences, Inc. | Crosslinked particles |
| EP3458084B1 (de) | 2016-05-16 | 2020-04-01 | Intarcia Therapeutics, Inc | Für den glucagonrezeptor selektive polypeptide und verfahren zu deren verwendung |
| USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
| USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
| EP3565580B1 (de) | 2017-01-03 | 2024-03-06 | i2o Therapeutics, Inc. | Kontinuierlicher verabreichung von exenatid und co-verabreichung von acetaminophen, ethinylestradiol oder levonorgestrel |
| US11905377B2 (en) | 2019-01-17 | 2024-02-20 | Pendant Biosciences, Inc. | Factors controlling drug release in cross-linked poly(valerolactone) based matrices |
| EP3986466A1 (de) * | 2019-06-18 | 2022-04-27 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften E. V. | Ortsspezifische, kinetisch inerte konjugation von markierungen und/oder trägern an zielmolekülen wie his-tag-proteine über metallkomplexreagenzien |
Family Cites Families (115)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5120712A (en) * | 1986-05-05 | 1992-06-09 | The General Hospital Corporation | Insulinotropic hormone |
| US6849708B1 (en) * | 1986-05-05 | 2005-02-01 | The General Hospital Corporation | Insulinotropic hormone and uses thereof |
| US5118666A (en) * | 1986-05-05 | 1992-06-02 | The General Hospital Corporation | Insulinotropic hormone |
| US7138486B2 (en) | 1986-05-05 | 2006-11-21 | The General Hospital Corporation | Insulinotropic hormone derivatives and uses thereof |
| US5614492A (en) * | 1986-05-05 | 1997-03-25 | The General Hospital Corporation | Insulinotropic hormone GLP-1 (7-36) and uses thereof |
| US5527524A (en) * | 1986-08-18 | 1996-06-18 | The Dow Chemical Company | Dense star polymer conjugates |
| US4857311A (en) | 1987-07-31 | 1989-08-15 | Massachusetts Institute Of Technology | Polyanhydrides with improved hydrolytic degradation properties |
| US5681543A (en) * | 1988-02-29 | 1997-10-28 | Shering Aktiengesellschaft | Polymer-bonded complexing agents and pharmaceutical agents containing them for MRI |
| US5776894A (en) * | 1988-12-05 | 1998-07-07 | Novartis Ag | Chelated somatostatin peptides and complexes thereof, pharmaceutical compositions containing them and their use in treating tumors |
| US5554388A (en) * | 1989-02-25 | 1996-09-10 | Danbiosyst Uk Limited | Systemic drug delivery compositions comprising a polycationi substance |
| US5744166A (en) * | 1989-02-25 | 1998-04-28 | Danbiosyst Uk Limited | Drug delivery compositions |
| US5542935A (en) | 1989-12-22 | 1996-08-06 | Imarx Pharmaceutical Corp. | Therapeutic delivery systems related applications |
| JPH07503943A (ja) * | 1991-10-29 | 1995-04-27 | クローバー コンソリデイテッド，リミテッド | 封入及び薬剤放出に有用な架橋性の多糖類、ポリカチオン及び脂質 |
| US5770563A (en) * | 1991-12-06 | 1998-06-23 | The United States Of America As Represented By The Department Of Health And Human Services | Heparin- and sulfatide binding peptides from the type I repeats of human thrombospondin and conjugates thereof |
| DE69333434T2 (de) * | 1992-04-03 | 2005-03-03 | The Regents Of The University Of California, Oakland | Selbstorganisierendes system zur verabreichung von polynukleotiden enthaltend ein amphiphatisches peptid |
| US6113946A (en) * | 1992-04-03 | 2000-09-05 | The Regents Of The University Of California | Self-assembling polynucleotide delivery system comprising dendrimer polycations |
| US5871710A (en) * | 1992-09-04 | 1999-02-16 | The General Hospital Corporation | Graft co-polymer adducts of platinum (II) compounds |
| WO1994005203A1 (en) | 1992-09-04 | 1994-03-17 | The General Hospital Corporation | Biocompatible polymers containing diagnostic or therapeutic moieties |
| US5395619A (en) | 1993-03-03 | 1995-03-07 | Liposome Technology, Inc. | Lipid-polymer conjugates and liposomes |
| US6284727B1 (en) * | 1993-04-07 | 2001-09-04 | Scios, Inc. | Prolonged delivery of peptides |
| US5605672A (en) | 1993-06-09 | 1997-02-25 | The General Hospital Corporation | Blood pool imaging composition and method of its use |
| US5763585A (en) | 1993-10-13 | 1998-06-09 | Anergen, Inc. | Method of making MHC-peptide complexes using metal chelate affinity chromatography |
| PL181064B1 (pl) * | 1994-03-07 | 2001-05-31 | Dendritech Inc | Kompleks polimeru typu gęstej gwiazdy, kompozycja do przenoszenia materiału genetycznego i sposób wytwarzania kompleksu polimeru typu gęstej gwiazdy |
| AU710504B2 (en) * | 1994-03-15 | 1999-09-23 | Brown University Research Foundation | Polymeric gene delivery system |
| US5466467A (en) | 1994-03-30 | 1995-11-14 | The United States Of America As Represented By The Secretary Of The Navy | Liposomes containing polymerized lipids for non-covalent immobilization of proteins and enzymes |
| GB9409496D0 (en) * | 1994-05-12 | 1994-06-29 | London Health Ass | Method for improving glycaemic control in diabetes |
| US20010006943A1 (en) * | 1994-12-23 | 2001-07-05 | Ejvind Jensen | Protracted GLP-1 compositions |
| US5834428A (en) * | 1995-04-14 | 1998-11-10 | 1149336 Ontario Inc. | Glucagon-like peptide-2 and its therapeutic use |
| US5929031A (en) * | 1995-05-02 | 1999-07-27 | Baxter Biotech Technology Sarl | Storage stable hemoglobin solutions |
| US5855610A (en) | 1995-05-19 | 1999-01-05 | Children's Medical Center Corporation | Engineering of strong, pliable tissues |
| US6521211B1 (en) * | 1995-06-07 | 2003-02-18 | Bristol-Myers Squibb Medical Imaging, Inc. | Methods of imaging and treatment with targeted compositions |
| US5891418A (en) * | 1995-06-07 | 1999-04-06 | Rhomed Incorporated | Peptide-metal ion pharmaceutical constructs and applications |
| CA2224253A1 (en) | 1995-06-09 | 1996-12-27 | Martin J. Macphee | Chitin hydrogels, methods of their production and use |
| MY147327A (en) * | 1995-06-29 | 2012-11-30 | Novartis Ag | Somatostatin peptides |
| US5942253A (en) | 1995-10-12 | 1999-08-24 | Immunex Corporation | Prolonged release of GM-CSF |
| AU730969B2 (en) | 1995-10-19 | 2001-03-22 | University Of Washington | Discrete-length polyethylene glycols |
| CN1304058C (zh) * | 1996-03-12 | 2007-03-14 | Pg－Txl有限公司 | 水溶性紫杉醇产品 |
| US6254854B1 (en) | 1996-05-24 | 2001-07-03 | The Penn Research Foundation | Porous particles for deep lung delivery |
| US7235627B2 (en) * | 1996-08-30 | 2007-06-26 | Novo Nordisk A/S | Derivatives of GLP-1 analogs |
| US6006753A (en) | 1996-08-30 | 1999-12-28 | Eli Lilly And Company | Use of GLP-1 or analogs to abolish catabolic changes after surgery |
| US6277819B1 (en) * | 1996-08-30 | 2001-08-21 | Eli Lilly And Company | Use of GLP-1 or analogs in treatment of myocardial infarction |
| UA65549C2 (uk) * | 1996-11-05 | 2004-04-15 | Елі Ліллі Енд Компані | Спосіб регулювання ожиріння шляхом периферійного введення аналогів та похідних glp-1 (варіанти) та фармацевтична композиція |
| JPH10158195A (ja) * | 1996-11-28 | 1998-06-16 | Res Inst For Prod Dev | 配位結合を利用した薬物−高分子複合体製剤の調製方法 |
| US6458373B1 (en) | 1997-01-07 | 2002-10-01 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
| US6120751A (en) | 1997-03-21 | 2000-09-19 | Imarx Pharmaceutical Corp. | Charged lipids and uses for the same |
| IL134084A0 (en) * | 1997-07-18 | 2001-04-30 | Infimed Inc | Biodegradable macromers for the controlled release of biologically active substances |
| DE19740069A1 (de) * | 1997-09-12 | 1999-03-18 | Clariant Gmbh | Mischungen von langkettigen Phosphorsäurealkylestern |
| US6468532B1 (en) * | 1998-01-22 | 2002-10-22 | Genentech, Inc. | Methods of treating inflammatory diseases with anti-IL-8 antibody fragment-polymer conjugates |
| US6703359B1 (en) * | 1998-02-13 | 2004-03-09 | Amylin Pharmaceuticals, Inc. | Inotropic and diuretic effects of exendin and GLP-1 |
| US6998387B1 (en) * | 1998-03-19 | 2006-02-14 | Amylin Pharmaceuticals, Inc. | Human appetite control by glucagon-like peptide receptor binding compounds |
| US6509323B1 (en) | 1998-07-01 | 2003-01-21 | California Institute Of Technology | Linear cyclodextrin copolymers |
| ES2335066T3 (es) * | 1998-08-10 | 2010-03-18 | The Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services | Diferenciacion de celulas no productoras de insulina en celulas productoras de insulina glp-1 o exendina-4 y utilizaciones de las mismas. |
| WO2000009089A1 (en) | 1998-08-12 | 2000-02-24 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Liposomal bupivacaine compositions prepared using an ammonium sulfate gradient |
| US6284725B1 (en) * | 1998-10-08 | 2001-09-04 | Bionebraska, Inc. | Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused tissue |
| CN1338924A (zh) * | 1999-01-08 | 2002-03-06 | 艾米斯菲尔技术有限公司 | 聚合物输送剂和输送剂化合物 |
| US6365173B1 (en) * | 1999-01-14 | 2002-04-02 | Efrat Biopolymers Ltd. | Stereocomplex polymeric carriers for drug delivery |
| US6395299B1 (en) | 1999-02-12 | 2002-05-28 | Biostream, Inc. | Matrices for drug delivery and methods for making and using the same |
| AU769571B2 (en) * | 1999-04-28 | 2004-01-29 | Universitat Zurich | Polyionic coatings in analytic and sensor devices |
| CA2386626A1 (en) | 1999-10-15 | 2001-04-26 | Richard Murphy | Targeted vectors |
| US6569832B1 (en) * | 1999-11-12 | 2003-05-27 | Novo Nordisk A/S | Inhibition of beta cell degeneration |
| US6593308B2 (en) * | 1999-12-03 | 2003-07-15 | The Regents Of The University Of California | Targeted drug delivery with a hyaluronan ligand |
| WO2001068112A2 (en) * | 2000-03-14 | 2001-09-20 | Goeke Burkhard | Effects of glucagon-like peptide-1 (7-36) on antro-pyloro-duodenal motility |
| US6998137B2 (en) * | 2000-04-07 | 2006-02-14 | Macromed, Inc. | Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix |
| US6589549B2 (en) * | 2000-04-27 | 2003-07-08 | Macromed, Incorporated | Bioactive agent delivering system comprised of microparticles within a biodegradable to improve release profiles |
| ES2290142T3 (es) | 2000-05-16 | 2008-02-16 | Bolder Biotechnology, Inc. | Metodos para replegamiento de proteinas que contiene residuos de cisteina libre. |
| DE60134403D1 (de) * | 2000-05-19 | 2008-07-24 | Amylin Pharmaceuticals Inc | Behandlung des akuten koronaren syndroms mit glp-1 |
| US6338859B1 (en) | 2000-06-29 | 2002-01-15 | Labopharm Inc. | Polymeric micelle compositions |
| DK2364734T3 (en) | 2000-07-21 | 2017-10-30 | Revance Therapeutics Inc | Biological multicomponent transport systems |
| US20040092432A1 (en) * | 2000-08-24 | 2004-05-13 | Thomas Jefferson University | Peptide compositions with effects on cerebral health |
| US6521736B2 (en) | 2000-09-15 | 2003-02-18 | University Of Massachusetts | Amphiphilic polymeric materials |
| DE60142351D1 (de) * | 2000-10-20 | 2010-07-22 | Amylin Pharmaceuticals Inc | Behandlung von hypoaktivem myokard und diabetischer herzmyopathie mit einem glp-1 peptid |
| US20020132254A1 (en) * | 2000-11-30 | 2002-09-19 | Twu Jesse J. | Molecular labeling and assay systems using poly (amino acid)-metal ion complexes as linkers |
| US7199217B2 (en) * | 2000-12-13 | 2007-04-03 | Eli Lilly And Company | Amidated glucagon-like peptide-1 |
| EP1390061A2 (de) * | 2000-12-13 | 2004-02-25 | Eli Lilly And Company | Chronisches behandlungsverfahren unter verwendung von glukagon-ähnlichen insulinotropischen peptiden |
| ITMI20011057A1 (it) * | 2001-05-22 | 2002-11-22 | Bracco Imaging Spa | Preparazione ed uso di peptidi ciclici e ramificati e loro deriati marcati come agenti terapeutici agonisti o antagonisti della colecistochi |
| WO2002098348A2 (en) | 2001-06-01 | 2002-12-12 | Eli Lilly And Company | Glp-1 formulations with protracted time action |
| DK1412384T3 (da) * | 2001-06-28 | 2008-04-28 | Novo Nordisk As | Stabil formulering af modificeret GLP-1 |
| US6586524B2 (en) * | 2001-07-19 | 2003-07-01 | Expression Genetics, Inc. | Cellular targeting poly(ethylene glycol)-grafted polymeric gene carrier |
| HUP0501192A3 (en) * | 2001-08-23 | 2006-06-28 | Lilly Co Eli | Glucagon-like peptide-1 analogs |
| CN1561224A (zh) * | 2001-10-01 | 2005-01-05 | 伊莱利利公司 | 降低与严重疾病相关的死亡率和发病率的方法 |
| US7041646B2 (en) * | 2001-10-05 | 2006-05-09 | Bayer Pharmaceuticals Corporation | Methods of treating type 2 diabetes with peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists |
| MXPA04005025A (es) * | 2001-11-26 | 2005-04-08 | Daiichi Suntory Pharma Co Ltd | Composiciones farmaceuticas para absorcion nasal. |
| AU2003208945B2 (en) * | 2002-02-20 | 2008-05-01 | Emisphere Technologies, Inc | Method for administering GLP-1 molecules |
| US7635463B2 (en) * | 2002-02-27 | 2009-12-22 | Pharmain Corporation | Compositions for delivery of therapeutics and other materials |
| US20050260259A1 (en) * | 2004-04-23 | 2005-11-24 | Bolotin Elijah M | Compositions for treatment with glucagon-like peptide, and methods of making and using the same |
| JP2005524657A (ja) | 2002-02-27 | 2005-08-18 | ファーメイン， エルティーディー． | 治療剤及び他の物質を送達するための組成物、及び、前記組成物を作製し使用する方法 |
| EP1525219B1 (de) * | 2002-07-04 | 2009-05-27 | Zealand Pharma A/S | Glp-1 und behandlungsmethode für diabetes |
| EP1539210A4 (de) | 2002-09-06 | 2006-06-07 | Bayer Pharmaceuticals Corp | Modifizierte glp-1-rezeptoragonisten und ihrer pharmakologischen anwendungsverfahren |
| US20040209803A1 (en) * | 2002-12-19 | 2004-10-21 | Alain Baron | Compositions for the treatment and prevention of nephropathy |
| US7790681B2 (en) | 2002-12-17 | 2010-09-07 | Amylin Pharmaceuticals, Inc. | Treatment of cardiac arrhythmias with GLP-1 receptor ligands |
| CN1767815A (zh) * | 2003-03-31 | 2006-05-03 | 阿尔萨公司 | 非水单相载体和使用这类载体的制剂 |
| ES2425221T3 (es) * | 2003-05-30 | 2013-10-14 | Amylin Pharmaceuticals, Llc | Nuevos métodos y composiciones para suministro por vía transmucosa potenciado de péptidos y proteínas |
| ES2375056T3 (es) * | 2003-06-03 | 2012-02-24 | Novo Nordisk A/S | Composiciones pept�?dicas farmacéuticas estabilizadas. |
| EP2292254A3 (de) * | 2003-06-03 | 2011-12-14 | Novo Nordisk A/S | Stabilisierte pharmazeutische Peptidzusammensetzungen |
| US20060247167A1 (en) * | 2003-09-01 | 2006-11-02 | Novo Nordisk A/S | Stable formulations of peptides |
| AR047776A1 (es) * | 2003-12-16 | 2006-02-22 | Sod Conseils Rech Applic | Composiciones farmaceuticas glp - 1 |
| WO2005084180A2 (en) | 2003-12-19 | 2005-09-15 | University Of Cincinnati | Polyamides and polyamide complexes for delivery of oligonucleotide decoys |
| US20060286129A1 (en) | 2003-12-19 | 2006-12-21 | Emisphere Technologies, Inc. | Oral GLP-1 formulations |
| US20050143303A1 (en) * | 2003-12-26 | 2005-06-30 | Nastech Pharmaceutical Company Inc. | Intranasal administration of glucose-regulating peptides |
| US20060074025A1 (en) * | 2003-12-26 | 2006-04-06 | Nastech Pharmaceutical Company Inc. | Therapeutic formulations for transmucosal administration that increase glucagon-like peptide-1 bioavailability |
| US8974774B2 (en) * | 2004-03-03 | 2015-03-10 | Revance Therapeutics, Inc. | Compositions and methods for topical diagnostic and therapeutic transport |
| FR2867679B1 (fr) * | 2004-03-17 | 2008-08-22 | Oreal | Composition cosmetiques comprenant des polyamines modifiees et utilisations desdites compositions. |
| US7985424B2 (en) | 2004-04-20 | 2011-07-26 | Dendritic Nanotechnologies Inc. | Dendritic polymers with enhanced amplification and interior functionality |
| NZ550604A (en) * | 2004-04-20 | 2010-09-30 | Dendritic Nanotechnologies Inc | Dendritic polymers with enhanced amplification and interior functionality |
| US7534449B2 (en) | 2004-07-01 | 2009-05-19 | Yale University | Targeted and high density drug loaded polymeric materials |
| WO2006014425A1 (en) * | 2004-07-02 | 2006-02-09 | Biovalve Technologies, Inc. | Methods and devices for delivering glp-1 and uses thereof |
| CA2910494C (en) * | 2004-07-19 | 2018-10-23 | Biocon Limited | Insulin-oligomer conjugates, formulations and uses thereof |
| US7285529B2 (en) * | 2005-02-28 | 2007-10-23 | Gene Tools, Llc | Embedder compositions and methods for detecting and killing cells in acidic areas of tumors |
| US20090202497A1 (en) | 2005-08-23 | 2009-08-13 | The General Hospital Corporation | Use of glp-1, glp-1 derivatives or glp-1 fragments for skin regeneration, stimulation of hair growth, or treatment of diabetes |
| US20100041612A1 (en) | 2005-09-08 | 2010-02-18 | Martin Beinborn | Fragments of the Glucagon-Like Peptide-1 and Uses Thereof |
| AU2006308511B2 (en) | 2005-10-25 | 2013-06-13 | Starpharma Pty Limited | Macromolecular compounds having controlled stoichiometry |
| HUE029798T2 (en) | 2005-11-04 | 2017-03-28 | Glaxosmithkline Llc | Methods of administering hypoglycemic agents |
| AU2006330610B2 (en) * | 2005-12-19 | 2012-08-16 | Pharmain Corporation | Hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same |
| WO2007082331A1 (en) | 2006-01-20 | 2007-07-26 | Starpharma Pty Limited | Modified macromolecule |
| US8563527B2 (en) * | 2007-08-20 | 2013-10-22 | Pharmain Corporation | Oligonucleotide core carrier compositions for delivery of nucleic acid-containing therapeutic agents, methods of making and using the same |
-
2003
- 2003-02-27 JP JP2003570887A patent/JP2005524657A/ja active Pending
- 2003-02-27 US US10/378,100 patent/US7138105B2/en not_active Expired - Lifetime
- 2003-02-27 EP EP03716207A patent/EP1478406B1/de not_active Expired - Lifetime
- 2003-02-27 CA CA2476589A patent/CA2476589C/en not_active Expired - Lifetime
- 2003-02-27 AT AT03716207T patent/ATE494010T1/de not_active IP Right Cessation
- 2003-02-27 AU AU2003219922A patent/AU2003219922B2/en not_active Expired
- 2003-02-27 DE DE60335608T patent/DE60335608D1/de not_active Expired - Lifetime
- 2003-02-27 WO PCT/US2003/005937 patent/WO2003072143A1/en active Application Filing
-
2006
- 2006-07-05 US US11/428,803 patent/US7790140B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP1478406A4 (de) | 2006-01-11 |
| EP1478406A1 (de) | 2004-11-24 |
| US20060239924A1 (en) | 2006-10-26 |
| AU2003219922A1 (en) | 2003-09-09 |
| CA2476589C (en) | 2014-02-25 |
| WO2003072143A9 (en) | 2004-03-04 |
| CA2476589A1 (en) | 2003-09-04 |
| US7790140B2 (en) | 2010-09-07 |
| JP2005524657A (ja) | 2005-08-18 |
| US20030224974A1 (en) | 2003-12-04 |
| WO2003072143A1 (en) | 2003-09-04 |
| US7138105B2 (en) | 2006-11-21 |
| AU2003219922B2 (en) | 2009-09-10 |
| EP1478406B1 (de) | 2011-01-05 |
| ATE494010T1 (de) | 2011-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60335608D1 (de) | Zusammensetzungen zur abgabe von therapeutika und anderen materialien und verfahren zu ihrer herstellung und verwendung | |
| DE60021729D1 (de) | Photosensibilisatoren enthaltende antimikrobielle zusammensetzung, gegenstände und verfahren zur verwendung | |
| DE60043229D1 (de) | Zusammensetzung zur gefässbeschichtung | |
| DE69933945D1 (de) | Polymer, verfahren zu seiner herstellung und zusammensetzung | |
| DE602004031134D1 (de) | Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa | |
| ATE537826T1 (de) | Zusammensetzungen aus r(+)- und s(-)-pramipexol sowie verfahren zu ihrer anwendung | |
| UA88463C2 (ru) | Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции | |
| DE60328421D1 (de) | Verfahren zur herstellung von super-hydrophoben oberflächen, daraus hergestellte oberflächen und deren verwendung | |
| DE50015883D1 (de) | Flächiges Implantat, Verfahren zu seiner Herstellung und Verwendung in der Chirurgie | |
| ATE520781T1 (de) | Verfahren zur veränderung des gehalts von speicherstoffen in pflanzen | |
| DE602004001956D1 (de) | Sehr dünner, hochkohlenstoffhaltiger Stahldraht und Verfahren zu dessen Herstellung | |
| DE602004012796D1 (de) | Dichtungsprofil, Verfahren zu seiner Herstellung und Formwerkzeug zur Verwendung in diesem Verfahren | |
| DE69939475D1 (de) | Blockpolymerzusammensetzung, verfahren zu dessen herstellung und druckempfindliche klebstoffzusammensetzung | |
| DE602004015907D1 (de) | Konjugierte Dienamide, Verfahren zur deren Herstellung, diese enthaltende Zusammensetzungen sowie deren Verwendung | |
| DE60218524D1 (de) | Verfahren zur herstellung von wasserlöslichen methacrylpolymeren, wasserlösliche methacrylpolymere und deren verwendung | |
| DE60044169D1 (de) | Titan-Legierung mit verbesserter Kerbzähigkeit und Verfahren zur ihrer Herstellung | |
| DE502004012162D1 (de) | Elektrosterisch stabilisierte wässrige polyurethan-harze, verfahren zu ihrer herstellung und deren verwendung | |
| DE602005023468D1 (de) | Verwendung von zahnfleischfibroblasten zur behandlung von vaskulären zellen | |
| WO2007019550A3 (en) | Composition and method for use in cartilage affecting conditions | |
| DE60225449D1 (de) | Wildlederartiges kunstleder und verfahren zu dessen herstellung | |
| DE60041418D1 (de) | Zusammensetzung für hydrogele, hydrogel und dessen verwendung | |
| ATA6302000A (de) | Haftmittel für zahnprothesen und verfahren zu seiner herstellung | |
| EP1624859A4 (de) | Verfahren zur herstellung von thermogeformten zusammensetzungen mit acrylpolymerbindemitteln, pharmazeutische dosierformen und verfahren zu ihrer herstellung | |
| DE602004020874D1 (de) | Zusammensetzungen enthaltend hohe konzentration von kontrastmittel zur embolisierung von blutgefassen | |
| ATE445235T1 (de) | Verfahren zur herstellung von zinkpulver- agglomeraten und diese enthaltenden artikel |